Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

35.54USD
9:00pm BST
Change (% chg)

$-1.63 (-4.39%)
Prev Close
$37.17
Open
$37.26
Day's High
$37.56
Day's Low
$35.36
Volume
95,202
Avg. Vol
143,714
52-wk High
$41.80
52-wk Low
$14.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.162
Sep '17 0.00 -0.881
Jun '17 0.00 -0.867
Mar '17 0.00 -0.833
FY 2016 Dec '16 0.00 -0.902
Sep '16 0.00 -0.936
Jun '16 0.00 -0.674
Mar '16 0.00 -0.498
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 10 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 10 0.00 0.00 0.00 0.00
Year Ending Dec-18 10 0.00 0.00 0.00 0.00
Year Ending Dec-19 10 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 10 -0.82 -0.71 -1.02 -0.83
Quarter Ending Sep-18 10 -0.85 -0.74 -1.07 -0.82
Year Ending Dec-18 10 -3.34 -2.96 -4.22 -3.58
Year Ending Dec-19 9 -3.47 -3.01 -4.32 -3.67
LT Growth Rate (%) 1 4.40 4.40 4.40 6.40
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.44 32.31
P/E High - Last 5 Yrs. -- 280.78 46.12
P/E Low - Last 5 Yrs. -- 95.19 24.71
Beta -- 0.75 0.79
Price to Sales (TTM) -- 144.18 7.14
Price to Book (MRQ) 7.10 18.80 4.88
Price to Tangible Book (MRQ) 9.58 23.34 6.49
Price to Cash Flow (TTM) -- 117.05 24.37
% Owned Institutions 89.36 11.29 2.32

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.58
Dividend Yield - 5 Year Avg -- 0.20 0.78
Dividend 5 Year Growth Rate -- 1.96 4.08
Payout Ratio(TTM) -- 9.23 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.37 9.18
Sales (TTM) vs TTM 1 Yr. Ago -- 79.40 11.01
Sales - 5 Yr. Growth Rate -- 33.48 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.09 -66.76 23.62
EPS (TTM) vs TTM 1 Yr. Ago 8.86 -- --
EPS - 5 Yr. Growth Rate -- 46.41 10.39
Capital Spending - 5 Yr. Growth Rate -- 44.90 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.70 2.52
Current Ratio (MRQ) 7.74 5.99 3.58
LT Debt to Equity (MRQ) 0.00 23.56 11.61
Total Debt to Equity (MRQ) 0.00 26.01 14.31
Interest Coverage (TTM) -- -183.16 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.78 54.20
Gross Margin - 5 Yr. Avg. -- 55.29 52.34
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -149.45 15.90
Operating Margin (TTM) -- -587.01 3.62
Operating Margin - 5 Yr. Avg. -- -161.52 11.17
Pre-Tax Margin (TTM) -- -560.40 4.27
Pre-Tax Margin - 5 Yr. Avg. -- -168.41 11.48
Net Profit Margin (TTM) -- -548.74 0.90
Net Profit Margin - 5 Yr. Avg. -- -168.67 7.81
Effective Tax Rate (TTM) -- -0.45 31.67
Effective Tax Rate - 5 Yr. Avg. -- 18.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,441,753 786,924,448
Net Income/Employee (TTM) -465,072 684,681 92,306,248
Receivable Turnover (TTM) -- 6.13 5.48
Inventory Turnover (TTM) -- 2.39 3.46
Asset Turnover (TTM) 0.00 0.40 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -44.08 -0.78 10.35
Return on Assets - 5 Yr. Avg. -- 0.53 11.38
Return on Investment (TTM) -48.68 -0.73 12.97
Return on Investment - 5 Yr. Avg. -- 3.99 14.74
Return on Equity (TTM) -51.23 -2.77 14.84
Return on Equity - 5 Yr. Avg. -- -0.21 16.08
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 52.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Audentes Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 89.36%
# of Holders: 141
Total Shares Held: 32,771,446
3 Mo. Net Change: 4,174,104
# New Positions: 7
# Closed Positions: 1
# Increased Positions: 14
# Reduced Positions: 7
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.